Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 22,148.9 | 19,944.6 | 18,361.7 | 17,900.8 | 17,534.5 | 14,983.8 | 11,856.0 | 11,339.3 |
| Revenue growth | 11.1% | 8.6% | 2.6% | 2.1% | 17.0% | 26.4% | 4.6% | 1.9% |
| Cost of goods sold | 12,823.8 | 11,401.9 | 9,679.1 | 9,864.7 | 10,115.9 | 8,265.0 | 5,934.3 | 5,779.7 |
| Gross profit | 9,325.1 | 8,542.7 | 8,682.6 | 8,036.1 | 7,418.6 | 6,718.8 | 5,921.7 | 5,559.6 |
| Gross margin | 42.1% | 42.8% | 47.3% | 44.9% | 42.3% | 44.8% | 49.9% | 49.0% |
| Selling, general and administrative | 6,014.5 | 5,572.5 | 5,477.9 | 5,274.9 | 5,033.8 | 4,797.6 | 4,140.3 | 3,885.7 |
| EBITA | 3,335.5 | 2,839.4 | 3,132.3 | 2,741.1 | 2,037.6 | 1,982.8 | 1,743.4 | 1,661.5 |
| EBITA margin | 15.1% | 14.2% | 17.1% | 15.3% | 11.6% | 13.2% | 14.7% | 14.7% |
| Amortization of intangibles | 317.1 | 309.5 | 313.4 | 312.8 | 318.1 | 206.8 | 25.4 | 28.2 |
| EBIT | 3,018.4 | 2,529.9 | 2,818.9 | 2,428.3 | 1,719.5 | 1,776.0 | 1,718.0 | 1,633.2 |
| EBIT margin | 13.6% | 12.7% | 15.4% | 13.6% | 9.8% | 11.9% | 14.5% | 14.4% |
| Pre-tax income | 2,573.1 | 2,248.6 | 2,519.2 | 1,981.8 | 1,359.7 | 1,469.3 | 1,595.2 | 1,549.0 |
| Income taxes | 553.0 | 384.2 | 488.8 | 440.5 | 251.0 | -300.2 | 462.5 | 495.1 |
| Tax rate | 21.5% | 17.1% | 19.4% | 22.2% | 18.5% | | 29.0% | 32.0% |
| Earnings from continuing ops | 2,020.1 | 1,864.4 | 2,030.4 | 1,541.3 | 1,108.7 | 1,769.5 | 1,132.7 | 1,053.8 |
| Earnings from discontinued ops | | | | | | 0.0 | 1,132.7 | |
| Net income | 2,020.1 | 1,864.4 | 2,030.4 | 1,541.3 | 1,108.7 | 1,727.9 | 1,132.7 | 1,053.8 |
| Net margin | 9.1% | 9.3% | 11.1% | 8.6% | 6.3% | 11.5% | 9.6% | 9.3% |
| |
| Diluted EPS | $7.72 | $6.98 | $7.36 | $5.50 | $11.67 | $18.64 | $11.99 | $11.15 |
| Shares outstanding (diluted) | 261.8 | 267.1 | 275.8 | 280.3 | 95.0 | 94.9 | 94.5 | 94.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|